Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  EnteroMedics Inc    ETRM

 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 0,70 M
EBIT 2016 -30,2 M
Net income 2016 -30,5 M
Debt 2016 -
Yield 2016 -
Sales 2017 2,30 M
EBIT 2017 -32,8 M
Net income 2017 -28,5 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 4,40x
Capi. / Sales2017 1,34x
Capitalization 3,08 M
More Financials
Company
EnteroMedics, Inc. is a clinical development stage medical device company that engages in the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.Its proprietary neuroblocking technology is designed to... 
More about the company
Latest news on ENTEROMEDICS INC
06/28 ENTEROMEDICS INC : Other Events (form 8-K)
06/08 ENTEROMEDICS : Assigned Patent
05/13 ENTEROMEDICS INC : Notice of Delisting or Failure to Satisfy a Continued Listing..
05/06 ENTEROMEDICS INC : Entry into a Material Definitive Agreement, Results of Operat..
05/05 ENTEROMEDICS : Reports First Quarter 2016 Financial Results
05/02 ENTEROMEDICS : Announces Exclusive Federal Government Business Channel Sales Agr..
04/14 ENTEROMEDICS : Announces Publication of Results Showing Significantly Greater We..
02/17 ENTEROMEDICS : Results of Operations and Financial Condition, Financial Statemen..
02/17 ENTEROMEDICS : reports 4Q loss
02/17 ENTEROMEDICS : Reports Fourth Quarter 2015 Financial Results
More news
Sector news : Advanced Medical Equipment & Technology - NEC
06/28 RESMED : Awarded Group Purchasing Contract with Premier
06/28 SARTORIUS : acquires cell screening specialist IntelliCyt
06/27 AGILENT TECHNOLOGIES : to Acquire Assets of iLab Solutions, Leader in Cloud-Base..
06/27 RESMED INC. : Median Sales Estimate At $546.65
06/27 ILLUMINA : MolecularMD Enters Into a Collaboration Agreement With Illumina for D..
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
01/05 Medtech Approvals Of The Strange Kind
2015 EnteroMedics Will Do 1 For 15 Reverse Split - This Is Not A Good Way To Start..
2015 ENTEROMEDICS TO REVERSE SPLIT SHARES : 15
2015 EnteroMedics' (ETRM) CEO Dan Gladney on Q3 2015 Results - Earnings Call Trans..
2015 EnteroMedics - Investors Need To Have Realistic Expectations
Advertisement
Chart ENTEROMEDICS INC
Duration : Period :
EnteroMedics Inc Technical Analysis Chart | ETRM | US29365M2089 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions